VALPROAT DE SODIU AUROBINDO 300mg prolonged tablets medication leaflet

N03AG01 valproic acid + salts • Nervous system | Antiepileptics | Fatty acid derivatives

Valproic acid and its salts (e.g., sodium valproate) are used to treat epilepsy, bipolar disorder, and prevent migraines. They stabilize brain electrical activity, preventing seizures and episodes of mania or depression.

Valproic acid increases GABA (gamma-aminobutyric acid) levels, an inhibitory neurotransmitter, reducing neuronal excitability. It is indicated for generalized and focal epilepsy, bipolar disorder, and migraine prevention.

Side effects may include nausea, drowsiness, weight gain, or tremor. Rarely, it can affect the liver or pancreas. It is contraindicated during pregnancy due to the risk of congenital malformations. Treatment must be monitored by a doctor.

General data about VALPROAT DE SODIU AUROBINDO 300mg

Substance: valproic acid + salts

Date of last drug list: 01-05-2020

Commercial code: W66617007

Concentration: 300mg

Pharmaceutical form: prolonged tablets

Quantity: 28

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: APL SWIFT SERVICES (MALTA) LTD - MALTA

Holder: AUROBINDO PHARMA ROMANIA SRL - ROMANIA

Number: 12460/2019/07

Shelf life: 2 years

Concentrations available for valproic acid + salts

1000mg, 100mg, 150mg, 200mg, 200mg/5ml, 250mg, 300mg, 300mg/5ml, 400mg/4ml, 500mg, 50mg/ml, 57.64mg/ml, 600mg, 750mg

Other substances similar to valproic acid + salts